Casas Julio*

Otolaryngology - Head and Neck Oncosurgery/Plastic Surgery, Hospital Real San José, Valle Real, Guadalajara, Jalisco, Mexico

*Corresponding Author: Casas Julio, Otolaryngology - Head and Neck Oncosurgery/Plastic Surgery, Hospital Real San José, Valle Real, Guadalajara, Jalisco, Mexico.

Received: July 03, 2025; Published: August 01, 2025

Abstract

Head and neck cancer is the sixth most prevalent type of cancer globally, affecting approximately 900,000 individuals annually [1]. In the United States, around 67,000 cases are diagnosed each year. It is projected that by 2030, this number will increase by 30%, reaching an estimated 1.08 million cases per annum.

References

1. Sung H., et al. “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA Cancer Journal for Clinicians (2021).
2. Gh Rasool Bhat., et al. “Head and neck cancer: Current challenges and future perspectives”. Advances in Cancer Research 152 (2021): 67-102.
3. Pulte D and Brenner H. “Changes in survival in head and neck cancers in the late 20th and early 21^st century: a period analysis”. Oncologist9 (2010): 994-1001.
4. Lee YG., et al. “Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)”. BMC Cancer1 (2020): 813.

Citation

Citation: Casas Julio. “Head and Neck Cancer: Is there any Future in Treatment?". Acta Scientific Otolaryngology 7.9 (2025): 01-02.

Copyright

Copyright: © 2025 Casas Julio. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.